Therefore, in addition to overall and subgroup analyses, we evaluated the risk of rs1447295 with different prostate cancer clinical characteristics, including Gleason score, tumor stage and PSA level, and detailed results were shown in Table 3 and 4. This evidence concerns the gene KLK3 and prostate carcinoma.